We are live on
!
Find out more
Capstone Investment Advisors Portfolio holdings
AUM
$57.4B
1-Year Est. Return
26.91%
This Fund
S&P 500
This Quarter
Est. Return
+7.52%
1 Year Est. Return
+26.91%
3 Year Est. Return
+28.14%
5 Year Est. Return
+24.88%
10 Year Est. Return
+149.98%
AUM
$19.6B
AUM Growth
+$4.43B
(+29%)
Cap. Flow
+$2.96B
Cap. Flow
% of AUM
15.14%
Top 10 Holdings %
Top 10 Hldgs %
30.49%
Holding
1,499
New
193
Increased
971
Reduced
177
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$285M |
| 2 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$53.7M |
| 3 |
Morgan Stanley
MS
|
+$50.7M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$43M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$39.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$105M |
| 2 |
CZR
Caesars Entertainment Corporation
CZR
|
+$81.1M |
| 3 |
Gaotu Techedu
GOTU
|
+$45M |
| 4 |
WUBA
58.com Inc
WUBA
|
+$44.3M |
| 5 |
Willis Towers Watson
WTW
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 1.3% |
| 2 | Energy | 0.68% |
| 3 | Healthcare | 0.57% |
| 4 | Technology | 0.41% |
| 5 | Industrials | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PUT
American Tower
AMT
$79B
| $46.5M | 0.24% |
192,400
+62,400
| +48% | +$15.8M |
|
77
PUT
Bristol-Myers Squibb
BMY
$130B
| $44M | 0.23% |
730,300
+127,200
| +21% | +$7.66M |
|
78
PUT
Intuit
INTU
$92B
| $43.7M | 0.22% |
134,000
+9,800
| +8% | +$3.07M |
|
79
CALL
Visa
V
$677B
| $43.5M | 0.22% |
217,400
+89,700
| +70% | +$17.9M |
|
80
PUT
Vertex Pharmaceuticals
VRTX
$134B
| $43.2M | 0.22% |
158,800
+14,800
| +10% | +$4.08M |
|
81
PUT
Gilead Sciences
GILD
$168B
| $41.7M | 0.21% |
660,100
+145,000
| +28% | +$10.1M |
|
82
PUT
AbbVie
ABBV
$442B
| $41.1M | 0.21% |
469,200
-66,000
| -12% | -$6.21M |
|
83
PUT
Elevance Health
ELV
$84.7B
| $40.2M | 0.21% |
149,600
+36,200
| +32% | +$9.74M |
|
|
MXIM
84
DELISTED
Maxim Integrated Products
MXIM
| $39.7M | 0.2% |
+586,932
| New | +$39.7M |
|
85
PUT
T-Mobile US
TMUS
$192B
| $39.7M | 0.2% |
346,800
+127,400
| +58% | +$14.1M |
|
86
PUT
FedEx
FDX
$76.3B
| $38.6M | 0.2% |
153,500
+109,800
| +251% | +$22M |
|
87
PUT
RTX Corp
RTX
$302B
| $38.3M | 0.2% |
666,300
+96,800
| +17% | +$5.89M |
|
88
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
| $38.3M | 0.2% |
68,400
+24,400
| +55% | +$14.8M |
|
89
PUT
Pfizer
PFE
$152B
| $37.7M | 0.19% |
1,082,985
+375,646
| +53% | +$13.2M |
|
90
CALL
Comcast
CMCSA
$91B
| $37.7M | 0.19% |
814,500
+260,200
| +47% | +$11.3M |
|
91
PUT
Medtronic
MDT
$116B
| $37.4M | 0.19% |
360,000
+123,000
| +52% | +$12.4M |
|
92
PUT
Honeywell
HON
$72.9B
| $37.2M | 0.19% |
239,468
+82,228
| +52% | +$12.2M |
|
|
93
CALL
Pfizer
PFE
$152B
| $37M | 0.19% |
1,062,959
+546,815
| +106% | +$19.2M |
|
94
PUT
Chevron
CVX
$386B
| $36.9M | 0.19% |
512,600
+116,500
| +29% | +$9.8M |
|
95
PUT
Lockheed Martin
LMT
$138B
| $36.3M | 0.19% |
94,700
+12,900
| +16% | +$4.92M |
|
96
PUT
Colgate-Palmolive
CL
$73.6B
| $36.2M | 0.19% |
469,800
+107,200
| +30% | +$8.17M |
|
97
PUT
ServiceNow
NOW
$132B
| $36M | 0.18% |
371,000
+113,500
| +44% | +$10.1M |
|
98
PUT
CME Group
CME
$93.2B
| $35.5M | 0.18% |
212,000
+60,900
| +40% | +$10.3M |
|
99
PUT
Sherwin-Williams
SHW
$88.5B
| $35.5M | 0.18% |
152,700
+24,900
| +19% | +$5.44M |
|
100
CALL
Johnson & Johnson
JNJ
$626B
| $35M | 0.18% |
235,100
-4,600
| -2% | -$681K |
|
Similar funds
NAMI
Capstone Investment Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Capstone Investment Advisors held 1,499 positions worth $19.6B, up 29% from $15.1B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capstone Investment Advisors deployed $2.96B of net new capital in Q3 2020, opening 193 new positions and adding to 971 existing holdings. Its largest new stake was China Biologic Products Holdings, Inc.: 500,216 shares worth $55.6M.
By sector, the portfolio is most concentrated in Financials at 1.3% of assets, up from 1.2% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $105M trimmed.
- Capstone Investment Advisors's largest Q3 2020 buy was China Biologic Products Holdings, Inc.: 500,216 shares worth $55.6M.
- Capstone Investment Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $285M increase.
- Capstone Investment Advisors's biggest Q3 2020 reduction was Invesco QQQ Trust, cutting an estimated $105M.
- Capstone Investment Advisors fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $81.1M.
- Capstone Investment Advisors's ten largest holdings make up 30% of its $19.6B portfolio in Q3 2020.
- Capstone Investment Advisors opened 193 new positions and closed 115 in Q3 2020.
- Capstone Investment Advisors's portfolio value rose 29% quarter-over-quarter to $19.6B.
Based on Capstone Investment Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.